Candidate biomarkers in renal cell carcinoma

Proteomics

Volumn 7, Issue 24, 2007, Pages 4601-4612

  Seliger, Barbara ^a   Dressler, Sven P ^a   Lichtenfels, Rudolf ^a   Kellner, Roland ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b MERCK KGAA   (Germany)

Author keywords

Cancer; Diagnostic and prognostic markers; Renal cell carcinoma

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G; PROTEOME;

CANCER CELL CULTURE; KIDNEY CARCINOMA; KIDNEY EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; T LYMPHOCYTE;

CARCINOMA, RENAL CELL; EPITOPES; HUMANS; KIDNEY NEOPLASMS; NEOPLASM PROTEINS; PROTEOME; TUMOR MARKERS, BIOLOGICAL;

EID: 38049058719     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700415     Document Type: Review

References (62)

1. Ludwig, J. A0., Weinstein, J. N., Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 2005, 5, 845-856.
2. Miles, A. K., Matharoo-Ball, B., Li, G., Ahmad, M., Rees, R. C., The identification of human tumour antigens: Current status and future developments. Cancer Immunol. Immunother. 2006, 55, 996-1003.
3. Chatterjee, S. K., Zetter, B. R., Cancer biomarkers: Knowing the present and predicting the future. Future Oncol. 2005, 1, 37-50.
4. Schrader, A. J., Varga, Z., Hegele, A., Pfoertner, S. et al., Second-line strategies for metastatic renal cell carcinoma: Classics and novel approaches. J. Cancer Res. Clin. Oncol. 2006, 132, 137-149.
5. Rini, B. I., Halabi, S., Barrier, R., Margolin, K. A. et al., Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: A CALGB intergroup phase II study. Biol. Blood Marrow Transplant. 2006, 12, 778-785.
6. Gouttefangeas, C., Stenzl, A., Stevanovic, S., Rammensee, H. G., Immunotherapy of renal cell carcinoma. Cancer Immunol. Immunother. 2007, 56, 117-128.
7. Sarto, C., Marocchi, A., Sanchez, J. C., Giannone, D. et al., Renal cell carcinoma and normal kidney protein expression. Electrophoresis 1997, 18, 599-604.
8. Sarto, C., Frutiger, S., Cappellano, F., Sanchez, J. C. et al., Modified expression of plasma glutathione peroxidase and manganese superoxide dismutase in human renal cell carcinoma. Electrophoresis 1999, 20, 3458-3466.
9. Balabanov, S., Zimmermann, U., Protzel, C., Scharf, C. et al., Tumour-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. Eur. J. Biochem. 2001, 268, 5977-5980.
10. Klade, C. S., Voss, T., Krystek, E., Ahorn, H. et al., Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 2001, 1, 890-898.
11. Kellner, R., Lichtenfels, R., Atkins, D., Bukur, J. et al., Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance. Proteomics 2002, 2, 1743-1751.
12. Lichtenfels, R., Kellner, R., Bukur, J., Beck, J. et al., Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics 2002, 2, 561-570.
13. Lichtenfels, R., Kellner, R., Atkins, D., Bukur, J. et al., Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses. Biochim. Biophys. Acta 2003, 1646, 21-31.
14. Seliger, B., Menig, M., Lichtenfels, R., Atkins, D. et al., Identification of markers for the selection of patients undergoing renal cell carcinoma-specific immunotherapy. Proteomics 2003, 3, 979-990.
15. Unwin, R. D., Craven, R. A., Harnden, P., Hanrahan, S. et al., Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect. Proteomics 2003, 3, 1620-1632.
16. Unwin, R. D., Harnden, P., Pappin, D., Rahman, D. et al., Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma. Proteomics 2003, 3, 45-55.
17. Dallmann, K., Junker, H., Balabanov, S., Zimmermann, U. et al., Human agmatinase is diminished in the clear cell type of renal cell carcinoma. Int. J. Cancer 2004, 108, 342-347.
18. Sarto, C., Valsecchi, C., Magni, F., Tremolada, L. et al., Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics 2004, 4, 2252-2260.
19. Zimmermann, U., Balabanov, S., Giebel, J., Teller, S. et al., Increased expression and altered location of annexin IV in renal clear cell carcinoma: A possible role in tumour dissemination. Cancer Lett. 2004, 209, 111-118.
20. Hofmann, S., Gluckmann, M., Kausche, S., Schmidt, A. et al., Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS. Mol. Cell. Proteomics 2005, 4, 1888-1897.
21. Hwa, J. S., Park, H. J., Jung, J. H., Kam, S. C. et al., Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis. J. Korean Med. Sci. 2005, 20, 450-455.
22. Magni, F., Sarto, C., Valsecchi, C., Casellato, S. et al., Expanding the proteome two-dimensional gel electrophoresis reference map of human renal cortex by peptide mass fingerprinting. Proteomics 2005, 5, 816-825.
23. Perego, R. A., Bianchi, C., Corizzato, M., Eroini, B. et al., Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues. J. Proteome Res. 2005, 4, 1503-1510.
24. Poznanovic, S., Wozny, W., Schwall, G. P., Sastri, C. et al., Differential radioactive proteomic analysis of microdissected renal cell carcinoma tissue by 54 cm isoelectric focusing in serial immobilized pH gradient gels. J. Proteome Res. 2005, 4, 2117-2125.
25. Seliger, B., Lichtenfels, R., Atkins, D., Bukur, J. et al., Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. Proteomics 2005, 5, 2631-2640.
26. Tremolada, L., Magni, F., Valsecchi, C., Sarto, C. et al., Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma. Proteomics 2005, 5, 788-795.
27. Alchanati, I., Nallar, S. C., Sun, P., Gao, L. et al., A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene 2006, 25, 7138-7147.
28. Craven, R. A., Hanrahan, S., Totty, N., Harnden, P. et al., Proteomic identification of a role for the von Hippel-Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma. Proteomics 2006, 6, 3880-3893.
29. Craven, R. A., Stanley, A. J., Hanrahan, S., Dods, J. et al., Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma. Proteomics 2006, 6, 2853-2864.
30. Perroud, B., Lee, J., Valkova, N., Dhirapong, A. et al., Pathway analysis of kidney cancer using proteomics and metabolic profiling. Mol. Cancer 2006, 5, 64.
31. Zhuang, Z., Huang, S., Kowalak, J. A., Shi, Y. et al., From tissue phenotype to proteotype: Sensitive protein identification in microdissected tumor tissue. Int. J. Oncol. 2006, 28, 103-110.
32. Bloom, G. C., Eschrich, S., Zhou, J. X., Coppola, D., Yeatman, T. J., Elucidation of a protein signature discriminating six common types of adenocarcinoma. Int. J. Cancer. 2007, 120, 769-775.
33. Seliger, B., Fedorushchenko, A., Brenner, W., Ackermann, A. et al., Ubiquitin COOH-terminal hydrolase 1: A biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration. Clin. Cancer Res. 2007, 13, 27-37.
34. Gnarra, J. R., Lerman, M. I., Zbar, B., Linehan, W. M., Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin. Oncol. 1995, 22, 3-8.
35. Mostofi, F. K. a. D., C. J., Histological Typing of Kidney Tumors, WHO Springer, Berlin, Heidelberg, New York 1998.
36. Mulders, P., Figlin, R., deKernion, J. B., Wiltrout, R. et al., Renal cell carcinoma: Recent progress and future directions. Cancer Res. 1997, 57, 5189-5195.
37. Broghammer, E. L., Ratliff, T. L., Immunotherapy of urologic tumors: Principles and progress. Urol. Oncol. 2002, 7, 45-56.
38. Amato, R. J., Renal cell carcinoma: Review of novel single-agent therapeutics and combination regimens. Ann. Oncol. 2005, 16, 7-15.
39. Potti, A., George, D. J., Tyrosine kinase inhibitors in renal cell carcinoma. Clin. Cancer Res. 2004, 10, 6371S-6376S.
40. Sarto, C., Deon, C., Doro, G., Hochstrasser, D. F. et al., Contribution of proteomics to the molecular analysis of renal cell carcinoma with an emphasis on manganese superoxide dismutase. Proteomics 2001, 1, 1288-1294.
41. Rogers, M. A., Clarke, P., Noble, J., Munro, N. P. et al., Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: Identification of key issues affecting potential clinical utility. Cancer Res 2003, 63, 6971-6983.
42. Pieper, R., Gatlin, C. L., McGrath, A. M., Makusky, A. J. et al., Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004, 4, 1159-1174.
43. Won, Y., Song, H. J., Kang, T. W., Kim, J. J. et al., Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons. Proteomics 2003, 3, 2310-2316.
44. Toison, J., Bogumil, R., Brunst, E., Beck, H. et al., Serum protein profiling by SELDI mass spectrometry: Detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab. Invest. 2004, 84, 845-856.
45. Rossi, L., Martin, B. M., Hortin, G. L., White, R. L. et al., Inflammatory protein profile during systemic high dose interleukin-2 administration. Proteomics 2006, 6, 709-720.
46. Roessler, M., Rollinger, W., Palme, S., Hagmann, M. L. et al., Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin. Cancer Res. 2005, 11, 6550-6557.
47. Li, C., Xiao, Z., Chen, Z., Zhang, X. et al., Proteome analysis of human lung squamous carcinoma. Proteomics 2006, 6, 547-558.
48. Abramovitz, M., Leyland-Jones, B., A systems approach to clinical oncology: Focus on breast cancer. Proteome Sci. 2006, 4, 5.
49. Thoenes, W., Storkel, S., Rumpelt, H. J., Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol. Res. Pract. 1986, 181, 125-143.
50. Seliger, B., Lichtenfels, R., Kellner, R., Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses. Brief. Funct. Genomic. Proteomic. 2003, 2, 194-212.
51. Lichtenfels, R., Ackermann, A., Buker, J., Melchior, S. et al., Abstracts of British Electrophoresis Society Meeting 2001, York, UK, Abstract 18, p. 58.
52. Brichory, F., Beer, D., Le Naour, F., Giordano, T., Hanash, S., Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res. 2001, 61, 7908-7912.
53. Hong, S. H., Misek, D. E., Wang, H., Puravs, E. et al., An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Cancer Res. 2004, 64, 5504-5510.
54. Cui, J. W., Li, W. H., Wang, J., Li, A. L. et al., Proteomics-based identification of human acute leukemia antigens that induce humoral immune response. Mol. Cell. Proteomics 2005, 4, 1718-1724.
55. Feng, J. T., Liu, Y. K., Song, H. Y., Dai, Z. et al., Heat-shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 2005, 5, 4581-4588.
56. Le Naour, F., Misek, D. E., Krause, M. C., Deneux, L. et al., Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin. Cancer Res. 2001, 7, 3328-3335.
57. Falk, K., Rotzschke, O., Deres, K., Metzger, J. et al., Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast. J. Exp. Med. 1991, 174, 425-434.
58. Banks, R. E., Dunn, M. J., Forbes, M. A., Stanley, A. et al., The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis-preliminary findings. Electrophoresis 1999, 20, 689-700.
59. Sarto, C., Valsecchi, C., Mocarelli, P., Renal cell carcinoma: Handling and treatment. Proteomics 2002, 2, 1627-1629.
60. Craven, R. A., Totty, N., Harnden, P., Selby, P. J., Banks, R. E., Laser capture microdissection and two-dimensional Polyacrylamide gel electrophoresis: Evaluation of tissue preparation and sample limitations. Am. J. Pathol. 2002, 160, 815-822.
61. Rane, M. J., Pan, Y., Singh, S., Powell, D. W. et al., Heat shock protein 27 controls apoptosis by regulating Akt activation. J. Biol. Chem. 2003, 278, 27828-27835.
62. Simonnet, H., Alazard, N., Pfeiffer, K., Gallou, C. et al., Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 2002, 23, 759-768.